- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01088308
Hemodynamic Differentiation of Tachycardia Episodes Using Tissue Perfusion
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is being conducted to evaluate the feasibility to detect hemodynamic changes induced by supra-ventricular or ventricular tachycardia (SVT or VT) using tissue perfusion. Patients with a standard indication for either an electrophysiological study or an implantable cardioverter defibrillators(ICD) implant can be included into this study. Tissue perfusion and arterial blood pressure will be monitored and recorded throughout the electrophysiological procedure or ICD implant testing.
The study will be conducted in two consecutive phases. After completion of study phase I the study phase II will commence. Study phase I will be an acute non-invasive study in patients with an indication for an electrophysiological study, in whom tissue perfusion will be measured non-invasively with an epi-cutaneous tissue perfusion sensor. Phase II will be an acute invasive study in patients with an indication for the implantation of an ICD, in whom the tissue perfusion sensor will be placed in the surgically prepared device pocket on the muscular pectoralis or between the muscular pectoralis major and muscular pectoralis minor.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aachen, Germany, 52074
- Universitätsklinikum
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Indication for: an electrophysiological study with ventricular stimulation OR the implantation of an implantable cardioverter defibrillator (ICD)
- Patient is at least 18 years old.
- Patient is able and willing to give informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single Arm
All Patients underwent Intervention.
|
The right atria and ventricle of the subject will be electrically stimulated at high rate mimicking tachycardia episodes using electrodes placed in the right atria and ventricle.
Other Names:
A programmed electrical stimulation protocol will be performed using an electrode placed in the right ventricle.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in hemodynamic state during all tachycardia
Time Frame: <3 hours
|
The primary objective is to demonstrate for all tachycardia (supra-ventricular and ventricular tachycardia) a 90 % [two sided confidence interval of 75-100 %] agreement between the true hemodynamic state (stable or unstable) derived from arterial blood pressure measurement and the hemodynamic state determined by tissue perfusion
|
<3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in hemodynamic state during SVT
Time Frame: <3 hours
|
The secondary objective is to demonstrate for supra-ventricular tachycardia a 90 % [two sided confidence interval of 75-100 %] agreement between the true hemodynamic state (stable or unstable) derived from arterial blood pressure measurement and the hemodynamic state determined by tissue perfusion.
|
<3 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Emilia Stegemann, Dr. med, Universitätsklinikum Aachen
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TPS1010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrhythmias, Cardiac
-
Medtronic BRCCompletedAtrial Fibrillation | Risk of Cardiac ArrhythmiasNetherlands, Germany, Austria, Belgium, Canada, Czech Republic, Russian Federation, Slovakia
-
Medical University of LodzRecruiting
-
Boston Scientific CorporationRecruitingCardiac ArrythmiasUnited States, Italy, Monaco
-
Centro Cardiologico MonzinoMinistry of Health, ItalyCompletedCardiac ArrhythmiaItaly
-
EPD Solutions, A Philips CompanyPhilips HealthcareTerminatedCardiac ArrhythmiaUnited States
-
EPD Solutions, A Philips CompanyWithdrawn
-
Zoll Medical CorporationCompletedCardiac ArrhythmiaUnited States
-
Emory UniversityCompleted
-
Qompium NVCompleted
-
Blackpool Teaching Hospitals NHS Foundation TrustUnknownCardiac ArrhythmiaUnited Kingdom
Clinical Trials on High rate atrial and vetricular stimulation
-
Boston Scientific CorporationCompleted
-
Urmia University of Medical SciencesCompletedParoxysmal Atrial Fibrillation | Sick Sinus SyndromeIran, Islamic Republic of
-
Oslo University HospitalUniversity of OsloCompleted
-
M.D. Anderson Cancer CenterRecruitingMelanoma | Pancreatic Cancer | Cholangiocarcinoma Metastatic | Liver Malignant TumorsUnited States
-
Albany Medical CollegeCompleted
-
VA Office of Research and DevelopmentUniversity of IowaCompleted
-
Hospital Sirio-LibanesRecruitingChronic Kidney DiseasesBrazil
-
Lawson Health Research InstituteAcademic Medical Organization of Southwestern OntarioRecruiting
-
British Columbia Cancer AgencyUniversity of British Columbia; Vancouver Prostate Centre; BC Cancer FoundationRecruitingLocalized Prostate CarcinomaCanada
-
N.N. Petrov National Medical Research Center of...RecruitingBiochemical Relapse Free Survival | Complications Rates (Erectile Dysfunction, GI, GU Complications)Russian Federation